[Monitoring drug adherence for hypertensive and dyslipidemic patients in networks of community-based pharmacists and physicians].
Patient adherence is often poor for hypertension and dyslipidaemia. A monitoring of drug adherence might improve these risk factors control, but little is known in ambulatory care. We conducted a randomised controlled study in networks of community-based pharmacists and physicians in the canton of Fribourg to examine whether monitoring drug adherence with an electronic monitor (MEMS) would improve risk factor control among treated, but uncontrolled hypertensive and dyslipidemic patients. The results indicate that MEMS achieve a better blood pressure control and lipid profile, although its implementation requires considerable resources. The study also shows the value of collaboration between physicians and pharmacists in the field of patient adherence to improve ambulatory care of patients with cardiovascular risk factors.
Division de néphrologie et Consultation d'hypertension, CHUV, Lausanne.
Valérie
V
Santschi
Nicolas
N
Rodondi
Olivier
O
Bugnon
André
A
Pannatier
Michel
M
Burnier
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D003971:Diastole / Q000187:drug effects; D050171:Dyslipidemias / Q000188:drug therapy*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D006973:Hypertension / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008991:Monitoring, Physiologic / Q000379:methods*; D010349:Patient Compliance; D010595:Pharmacists; D010820:Physicians; D013599:Systole / Q000187:drug effects
D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D002784:Cholesterol
Suivi de l'adhésion thérapeutique des patients hypertendus ou dyslipi- démiques par les cercles de qualité médecins-pharmaciens.